Suppr超能文献

肥厚型心肌病患儿的风险分层分析及心源性猝死预防:困境与明晰

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity.

作者信息

Bonaventura Jiri, Maron Barry J, Berul Charles I, Rowin Ethan J, Maron Martin S

机构信息

Department of Cardiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.

Hypertrophic Cardiomyopathy Center, Lahey Hospital and Medical Center, Burlington, Massachusetts.

出版信息

Heart Rhythm O2. 2023 Jun 20;4(8):506-516. doi: 10.1016/j.hroo.2023.06.007. eCollection 2023 Aug.

Abstract

Hypertrophic cardiomyopathy (HCM) has been considered the most common cause of sudden death (SD) in the young. However, introduction of implantable cardioverter-defibrillators (ICDs) in HCM has proved highly effective and the mainstay of preventing SD in children, adolescents, and adults by terminating malignant ventricular tachyarrhythmias. Nevertheless, ICD decision making is generally regarded as more difficult in pediatrics, and the strategy for selecting ICD patients from this population remains without consensus. Prospective studies in HCM children and adolescents have shown the American Heart Association/American College of Cardiology traditional major risk marker strategy to be reliable with >90% sensitivity in selecting patients for SD prevention. International data in >2000 young HCM patients assembled over 20 years who were stratified by major risk markers showed ICDs effectively prevented SD in 20%. Alternatively, novel quantitative risk scoring initiatives provide 5-year risk estimates that are potentially useful as adjunctive tools to facilitate discussion of prophylactic ICD risks vs benefit but are as yet unsupported by prospective outcome studies. Risk scoring strategies are characterized by reasonable discriminatory statistical power (C-statistic 0.69-0.76) for identifying patients with SD events but with relatively low sensitivity, albeit with specificity comparable with the risk marker strategy. While some reticence for obligating healthy-appearing young patients to lifelong device implants is understandable, underutilization of the ICD in high-risk children and adolescents can represent a lost opportunity for fulfilling the long-standing aspiration of SD prevention. This review provides a critical assessment of the current strengths and weaknesses of SD risk stratification strategies in young HCM patients in an effort to clarify clinical decision making in this challenging subpopulation.

摘要

肥厚型心肌病(HCM)一直被认为是年轻人猝死(SD)的最常见原因。然而,事实证明,在HCM患者中植入植入式心脏复律除颤器(ICD)非常有效,是通过终止恶性室性心律失常来预防儿童、青少年和成人猝死的主要手段。尽管如此,ICD的决策在儿科通常被认为更具难度,从这一人群中选择ICD患者的策略仍未达成共识。对HCM儿童和青少年的前瞻性研究表明,美国心脏协会/美国心脏病学会的传统主要风险标志物策略在选择预防猝死的患者时具有可靠性,敏感性超过90%。在20多年里收集的2000多名年轻HCM患者的国际数据,根据主要风险标志物进行分层,结果显示ICD可有效预防20%的猝死。另外,新的定量风险评分方案可提供5年风险估计,这可能有助于作为辅助工具,促进对预防性ICD风险与益处的讨论,但目前尚未得到前瞻性结局研究的支持。风险评分策略的特点是,在识别有猝死事件的患者时具有合理的判别统计能力(C统计量为0.69 - 0.76),但敏感性相对较低,尽管其特异性与风险标志物策略相当。虽然让看似健康的年轻患者终身植入设备有些顾虑是可以理解的,但在高危儿童和青少年中ICD使用不足可能意味着失去了实现长期预防猝死愿望的机会。本综述对年轻HCM患者猝死风险分层策略的当前优势和劣势进行了批判性评估,以期阐明在这一具有挑战性的亚人群中的临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c781/10461211/f4105c93708e/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验